Overview

* Blade Q2 2025 revenue rises 4.2%, beating analyst expectations, per LSEG data

* Net loss improves to $3.7 mln, adjusted EBITDA rises to $3.2 mln

* Co to sell Passenger division to Joby Aviation for up to $125 mln

Outlook

* Blade reaffirms 2025 revenue guidance of $245-265 mln

* Company expects divestiture to be EBITDA and cash flow neutral

* Strata to focus on organic growth and capital allocation

* Partnership with Joby Aviation to provide access to eVTOLs for medical flights

Result Drivers

* MEDICAL SEGMENT GROWTH - Medical revenue increased 17.6% year-over-year, driven by new customers and higher revenue per block hour

* PASSENGER SEGMENT DECLINE - Passenger revenue decreased due to exit from Canada and reduced demand in U.S. following a helicopter incident

* COST REDUCTIONS - Improved net loss driven by $7.2 mln improvement in loss from operations and higher non-operating income

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $70.80 $64.10

Revenue mln mln (5

Analysts

)

Q2 Net -$3.74

Income mln

Q2 $75.76

Operatin mln

g

Expenses

Q2 -$4.95

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* Wall Street's median 12-month price target for Blade Air Mobility Inc ( BLDE ) is $6.00, about 26.2% above its August 4 closing price of $4.43

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)